THE PREVALENCE OF FOOT ULCERATION AND ITS CORRELATES IN TYPE-2 DIABETIC-PATIENTS - A POPULATION-BASED STUDY

被引:223
作者
KUMAR, S
ASHE, HA
PARNELL, LN
FERNANDO, DJS
TSIGOS, C
YOUNG, RJ
WARD, JD
BOULTON, AJM
机构
[1] Department of Medicine, Manchester Royal Infirmary, Manchester, Salford
[2] Department of Medicine, Royal Hallamshire Hospital, Sheffield, Salford
[3] Department of Medicine, Hope Hospital, Salford
关键词
FOOT ULCERATION; NEUROPATHY; PERIPHERAL VASCULAR DISEASE; NEUROPATHY DISABILITY SCORE;
D O I
10.1111/j.1464-5491.1994.tb00310.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prevalence of peripheral neuropathy, peripheral vascular disease, and foot ulceration in Type 2 diabetic patients in the community were determined in a community-based study. Eight hundred and eleven subjects (404 male, 407 female, mean age 65.4 (range 34-90) years, diabetes duration 7.4 (0-50) years) from 37 general practices in three UK cities were studied. Neuropathy was diagnosed clinically using modified neuropathy disability scores which were ascertained using structured interviews and clinical examinations by one observer in each city. Peripheral vascular disease was diagnosed if a history of revascularization was present or greater-than-or-equal-to 2 foot pulses were absent. History of current or previous foot ulceration was recorded. The prevalence of neuropathy was 41.6 % (95 % confidence limits 38.3-44.9 %) and the prevalence of PVD, 11 % (9.1-13.7 %). Forty-eight percent of neuropathic patients reported significant neuropathic symptoms. Forty-three patients (5.3 % (3.8-6.8 %)) had current or past foot ulcers; 20 of these were pure neuropathic ulcers, 13 neuroischaemic, 5 pure vascular, and 5 were unclassified. Multiple logistic regression showed history of amputation, neuropathy disability score, and peripheral vascular disease to be significantly associated with foot ulceration after adjusting for age and diabetes duration. A substantial proportion of Type 2 diabetic patients, often elderly patients who do not attend hospitals, suffered from peripheral neuropathy and peripheral vascular disease. These patients are at risk of foot ulceration and may benefit from preventive footcare.
引用
收藏
页码:480 / 484
页数:5
相关论文
共 35 条
[21]  
Boulton AJM, Knight G., Drury J., Ward JD, The prevalence of symptomatic, diabetic neuropathy in an insulin‐treated population, Diabetes Care, 8, pp. 125-128, (1985)
[22]  
Newrick PG, Boulton AJM, Ward JD, The distribution of diabetic neuropathy in a British clinic population, Diabetic Res Clin Pract, 2, pp. 263-268, (1986)
[23]  
Mayne N., Neuropathy in the diabetic and non‐diabetic populations, Lancet, 2, pp. 1313-1316, (1965)
[24]  
Pirart J., Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients between 1947 and 1973, Diabetes Care, 1, pp. 168-188, (1978)
[25]  
Consensus statement: report and recommendations of the San Antonio conference on diabetic neuropathy, Diabetes, 37, pp. 1000-1004, (1988)
[26]  
Dyck PJ, Karnes JL, Daube J., O'Brien P., Service FJ, Clinical and neuropathological criteria for the staging of diabetic polyneuropathy, Brain, 108, pp. 861-880, (1985)
[27]  
Dyck PJ, Detection, characterisation and staging of polyneuropathy assessed in diabetics, Muscle & Nerve, 11, pp. 21-32, (1988)
[28]  
Franklin GM, Kahn LB, Baxter J., Marshall JA, Hamman RF, Sensory neuropathy in non‐insulin dependent diabetes mellitus. The San Luis Valley study, Amer J Epidemiol, 131, pp. 633-643, (1990)
[29]  
Walters DA, Gatling W., Mullee MA, Hill RD, The prevalence of diabetic distal sensory neuropathy in an English community, Diabetic Med, 9, pp. 349-353, (1992)
[30]  
Marinelli MR, Beach KW, Glass MJ, Primozich JF, Strandness DE, Non‐invasive testing vs clinical evaluation of arterial disease, J Am Med Assoc, 241, pp. 2031-2034, (1979)